Categories AlphaGraphs, Analysis, Retail

Earnings Preview: Restructuring might cost Lowe’s in Q4, but aid in long term

Patio furniture maker Lowe’s Companies (LOW) is scheduled to post its fourth-quarter 2018 earnings on Feb. 27, before the opening bell.

All eyes would be on the bottom line with the Street expecting earnings of about 80 cents a share.

While earnings beat estimate in the previously reported third quarter, it stands to fact that it missed the four quarters before the beat.

For the upcoming fourth-quarter announcement, analysts predict about $15.7 billion in revenues.

In the quarter that passed, Lowe’s seems to have contained costs and improved cash flow from operations. For the full year 2018, Lowe’s expects total sales to grow 4% y-o-y with comparable sales growth of 2.5%, generating adjusted earnings between $5.08 and $5.13 a share.

While focusing on modernizing its way of sales, Lowe’s has also been busy streamlining the business. With plans to exit Mexico retails ops and shutter its Orchard Supply Hardware business, Lowe’s seems to be moving its resources to focus on the core business, and that is a good sign.

LOOKING BACK

In the previously reported third-quarter, Lowe’s Companies beat market estimates for revenue and earnings, but poor comp sales pulled the stock down following the results announcement.

Lowe's Earnings

In the third quarter, the furniture giant then saw total sales grow 3.8% while comp sales inch up 1.5%. US home improvement comp sales rose 2% in the three-month period. Adjusted EPS fell 1%.

In the quarter, Lowe’s benefited from a favorable macroeconomic environment that drove traffic to its stores and website, but these were offset by challenges in inventory and assortments.

 

 

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top